Response

Affiliations

¹ Section of Gastroenterology, Fox Chase Cancer Center, Philadelphia, Pennsylvania, USA.
² Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts, USA.
³ Department of Gastroenterology, Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire, USA; Department of Gastroenterology, Veterans Administration Medical Center, White River Junction, Vermont, USA.

Comment

Michael J Bartel et al. Gastrointest Endosc. 2018 Jul.

. 2018 Jul;88(1):201.

doi: 10.1016/j.gie.2018.02.036.

¹ Section of Gastroenterology, Fox Chase Cancer Center, Philadelphia, Pennsylvania, USA.
² Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts, USA.
³ Department of Gastroenterology, Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire, USA; Department of Gastroenterology, Veterans Administration Medical Center, White River Junction, Vermont, USA.

No abstract available

Comment on

Subsquamous intestinal metaplasia is common in treatment-naïve Barrett's esophagus.
Bartel MJ, Srivastava A, Gordon S, Rothstein RI, Pohl H. Bartel MJ, et al. Gastrointest Endosc. 2018 Jan;87(1):67-74. doi: 10.1016/j.gie.2017.06.024. Epub 2017 Jul 4. Gastrointest Endosc. 2018. PMID: 28687439
Esophageal submucosal glands as a potential source of subsquamous intestinal metaplasia in Barrett's esophagus.
Garman KS, McCall SJ. Garman KS, et al. Gastrointest Endosc. 2018 Jul;88(1):200-201. doi: 10.1016/j.gie.2018.01.027. Gastrointest Endosc. 2018. PMID: 29935616 No abstract available.